13F HOLDINGS REPORT
Knoll Capital Management, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001104659-23-021561
Total Value
$44.3M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Aldeyra Therapeutics Inc | ALDX | 1,948,090 | $13.6M | 30.60% |
| 2 | Biohaven Pharmactl Hldg Co L | BHVN | 450,422 | $6.3M | 14.11% |
| 3 | Altimmune Inc | ALT | 173,864 | $2.9M | 6.45% |
| 4 | Vaneck Gold Miners ETF | 92189F106 | 91,850 | $2.6M | 5.94% |
| 5 | Global X Silver Miners ETF 37954Y848 | 37954Y848 | 89,700 | $2.5M | 5.70% |
| 6 | Verona Pharma | 925050106 | 95,391 | $2.5M | 5.63% |
| 7 | Vaneck Junior Gold Miners ETF | 92189F791 | 53,150 | $1.9M | 4.28% |
| 8 | Applied Therapeutics Inc | 03828A101 | 2,450,000 | $1.9M | 4.20% |
| 9 | Booz Allen Hamilton HLDG COR | BAH | 13,000 | $1.4M | 3.07% |
| 10 | CVS Health Corp | CVS | 14,500 | $1.4M | 3.05% |
| 11 | Orgenesis, Inc. | ORGS | 634,738 | $1.2M | 2.79% |
| 12 | Thermo Fischer Scientific Inc | TMO | 2,100 | $1.2M | 2.61% |
| 13 | Avadel Pharmaceuticals Plc | 05337M104 | 150,000 | $1.1M | 2.42% |
| 14 | Altria Group Inc | MO | 22,700 | $1.0M | 2.34% |
| 15 | Visa | V | 4,850 | $1.0M | 2.27% |
| 16 | Blackstone Group LP | BX | 10,000 | $741,900 | 1.67% |
| 17 | OSISKO GOLD ROYALTIES LTD | 68827L101 | 235,000 | $607,710 | 1.37% |
| 18 | SEABRIDGE GOLD INC | SA | 41,000 | $515,780 | 1.16% |
| 19 | Anavex Life Sciences Corp | AVXL | 10,681 | $98,906 | 0.22% |
| 20 | HOOKIPA PHARMA | HOOK | 50,000 | $40,500 | 0.09% |
| 21 | Entera Bio Ltd | ENTX | 2,484,275 | $2,584 | 0.01% |